Kaken Pharmaceutical Revenue

Kaken Pharmaceutical had revenue of 33.12B JPY in the quarter ending September 30, 2024, with 83.77% growth. This brings the company's revenue in the last twelve months to 87.25B, up 20.61% year-over-year. In the fiscal year ending March 31, 2024, Kaken Pharmaceutical had annual revenue of 72.04B, down -1.29%.

Revenue (ttm)

87.25B

Revenue Growth

+20.61%

P/S Ratio

1.86

Revenue / Employee

76.87M

Employees

1,135

Market Cap

162.03B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2024	72.04B	-940.00M	-1.29%
Mar 31, 2023	72.98B	-3.05B	-4.01%
Mar 31, 2022	76.03B	1.06B	1.41%
Mar 31, 2021	74.98B	-14.25B	-15.97%
Mar 31, 2020	89.23B	-4.93B	-5.24%
Mar 31, 2019	Pro	Pro	Pro
Mar 31, 2018	Pro	Pro	Pro
Mar 31, 2017	Pro	Pro	Pro
Mar 31, 2016	Pro	Pro	Pro
Mar 31, 2015	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Chugai Pharmaceutical	1,170.61B
Daiichi Sankyo Company	1,795.99B
HOYA Corporation	812.74B
Takeda Pharmaceutical Company	4,579.02B
Otsuka Holdings	2,269.56B
Terumo	986.67B
Astellas Pharma	1,772.16B
Olympus	973.60B

Revenue Rankings

Kaken Pharmaceutical News

3 months ago - Spruce Biosciences Reports Third Quarter 2024 Financial Results and Provides Corporate Updates - Benzinga

More News